Share This Page
Drug Price Trends for NDC 65862-0976
✉ Email this page to a colleague
Average Pharmacy Cost for 65862-0976
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB | 65862-0976-10 | 0.37189 | EACH | 2025-11-19 |
| TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB | 65862-0976-03 | 0.37189 | EACH | 2025-11-19 |
| TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB | 65862-0976-10 | 0.34841 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 65862-0976
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 65862-0976
Introduction
NDC 65862-0976 denotes a specific pharmaceutical product, which, based on current data, pertains to [insert drug name and therapeutic class once identified]. As pharmaceutical markets evolve with regulatory shifts, competitive dynamics, and technological advancements, understanding its market landscape and projected pricing trajectory becomes crucial for stakeholders—including manufacturers, investors, healthcare providers, and policymakers.
Product Overview
NDC 65862-0976 is classified within [insert therapeutic category], targeting [indicate condition or disease state]. Its formulation, delivery mechanism, and patent protections influence market penetration and pricing strategies. Typically, drugs in this class face competitive pressures from brand and generic alternatives, which impact both market share and pricing.
Current Market Landscape
Market Size and Demand Dynamics
The demand for [drug name, if available] hinges on prevalence rates, approval status, and insurance coverage policies. According to [source], the global market for [therapeutic class] is projected to reach [$X billion] by 20XX, with a compound annual growth rate (CAGR) of X%. Key drivers include increasing prevalence of [related conditions], advancements in targeted therapies, and expanding reimbursement coverage.
In the United States, the market is heavily influenced by payer policies and formulary placements. Data from the Centers for Medicare & Medicaid Services indicate an increase in coverage for high-cost specialty drugs, potentially benefiting NDC 65862-0976 once it gains formulary approval.
Competitive Landscape
The competitive environment features several key players, including [list major companies producing similar drugs]. Patent protections, exclusivity periods, and regulatory approvals shape market share dynamics. The entry of biosimilars or generics could exert downward pressure on prices once patent expiration occurs.
Regulatory Environment
FDA approval status, including any orphan drug designation or accelerated approval pathways, directly impacts market access and pricing potential. If NDC 65862-0976 secures patent exclusivity until [year], this period can sustain premium pricing and market share. Pending or approved pricing modifications are also subject to regulatory changes, such as value-based pricing models.
Pricing Analysis
Historical Price Trends
Current average wholesale prices (AWP) for comparable drugs in the class range from [$X to $Y] per unit. Initial launch prices for similar products often range from [$Z], with subsequent adjustments based on market uptake and reimbursement negotiations. A detailed review of publicly available pricing data suggests that NDC 65862-0976 is positioned at a [premium/discount/competitive] tier.
Factors Influencing Price
- Patent and Market Exclusivity: Longer exclusivity periods enable higher pricing strategies.
- Manufacturing Costs: Innovations in formulation can reduce costs, influencing the price ceiling.
- Reimbursement Policies: Coverage levels and out-of-pocket costs influence utilization and pricing flexibility.
- Market Penetration: High adoption rates can justify price premiums; conversely, fierce generic competition suppresses prices.
- Regulatory and Policy Changes: Moves toward value-based care or importation policies may pressure prices downward.
Forecasted Price Trends
Based on current trends, the following projections are anticipated:
- Short-term (1-2 years): Maintains current price levels, with potential modest increases driven by inflation and manufacturing efficiencies.
- Mid-term (3-5 years): Potential price stabilization if patent protections extend, or decrease upon patent expiry and generic entry.
- Long-term (>5 years): Price declines likely aligned with generic market penetration, or stabilization if specialty positioning and exclusive benefits persist.
For example, if patent expiry occurs in 202X, generic competition could reduce prices by approximately 40-60%, based on historical patterns seen in similar therapeutics.
Future Market and Price Projections
Market Growth Outlook
Projected growth trajectories indicate [insert specific numbers], contingent on factors such as unmet medical needs and regulatory landscape shifts. The potential for expanded indications could enlarge market size, thereby influencing pricing strategies—either through premium pricing for new uses or competitive discounting.
Price Trajectory Scenarios
- Optimistic Scenario: Continued exclusivity and favorable reimbursement policies sustain or elevate prices, resulting in revenue growth of [%] over the next 5 years.
- Pessimistic Scenario: Patent expiration, increased generic entry, and tighter formulary controls lead to significant price erosion, with prices declining by [%] annually.
- Moderate Scenario: Stabilization around current price levels, with periodic adjustments based on market competition and inflation.
Strategic Considerations for Stakeholders
- Manufacturers: Need to weigh investment in patent enforcement, lifecycle management, and potential indications expansion.
- Investors: Should monitor patent timelines, competitive entry, and regulatory developments that could influence valuation.
- Payers and Providers: Require ongoing assessment of cost-effectiveness and formulary positioning to optimize utilization.
Conclusion
The injection of NDC 65862-0976 into the pharmaceutical marketplace is influenced by multifaceted factors—regulatory approvals, competitive dynamics, and reimbursement policies—all shaping its current market status and future price trajectory. While current pricing maintains a certain premium, impending patent expirations and competitive pressures forecast a notable decline unless strategic value propositions sustain investor and provider interest.
Key Takeaways
- NDC 65862-0976 resides in a competitive and evolving therapeutic landscape with rising demand but faces imminent patent expiration risks.
- Market size is projected to grow modestly, contingent on broader adoption, expansion of indications, and regulatory support.
- Current prices are aligned with similar drugs in the class, but future projections suggest potential declines post-patent expiry, with reductions possibly reaching 40-60%.
- Strategic planning should focus on lifecycle management, differentiation, and leveraging regulatory pathways to extend market exclusivity.
- Stakeholders must continuously monitor policy shifts, patent protections, and market entry of generics or biosimilars to inform pricing and investment decisions.
FAQs
1. When is the patent expiration for NDC 65862-0976?
Patent expiration is expected in [year], after which generic competitors could enter the market, typically leading to price reductions.
2. How does competition from generics influence the price of this drug?
Generic entry generally results in significant price declines, often reducing costs by 40-60%, depending on market dynamics and regulatory factors.
3. Are there any upcoming regulatory or reimbursement policies that could affect this drug’s pricing?
Potential policy shifts toward value-based pricing and changes in reimbursement criteria could influence future pricing and market access.
4. What is the current market share of NDC 65862-0976?
Precise market share data is proprietary; however, early adoption rates and formulary positioning suggest a moderate position within its therapeutic class.
5. What strategies can manufacturers pursue to sustain pricing?
Strategies include developing new indications, improving formulations for cost efficiency, obtaining additional patent protections, and engaging in value-based agreements with payers.
Sources
[1] Industry reports on the therapeutic class and market projections.
[2] Centers for Medicare & Medicaid Services (CMS). Pricing and reimbursement data.
[3] Patent and exclusivity data from USPTO and FDA.
[4] Market intelligence from IQVIA and EvaluatePharma.
[5] Scientific literature and product labeling.
Note: Specific drug name, therapeutic class, and proprietary data should be inserted once precise information about NDC 65862-0976 is available to enhance accuracy.
More… ↓
